VS-6766, VS-6063
VS-6766-201
Phase 2 small_molecule active
Quick answer
VS-6766, VS-6063 for Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) is a Phase 2 program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vera Therapeutics
- Indication
- Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active